… risk score for clinical manifestations of APS (the global APS score, or GAPSS) that takes into
account the combination of independent cardiovascular risk … aGAPSS for risk stratification of …

… Antiphospholipid syndrome (APS) is an autoimmune disease … positive levels of
antiphospholipid antibodies measured on 2 … could help in the risk stratification of patients with APS …

… worth mentioning the AntiPhospholipid syndrome alliance for … risk profile according to
aGAPSS might be at higher risk for … aid the treating clinician for risk stratification of APS patients. …

… -centred risk stratification, which includes aPL profile (number, titer, isotype), coexistence
of other auto-immune disease or an inherited thrombophilia, and cardiovascular risk factors. …

… of risk factor stratification and modification. In this study we aimed to assess the clinical utility
… the adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for the risk stratification of …

… The aPL profile, which refers to the type (LA, aCL, anti-β2GPI) and number of aPL (single,
double, or triple positive), is the most extensively studied and validated risk stratification …

… Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by …
[Citation44] proposed the risk stratification of patients with aPL based on the numbers of positive …

… risk stratification. They strongly recommend investigating coexisting inherited and acquired
thrombosis risk … and also by providing a risk-stratified approach. Furthermore, although the …

… In the frame of risk stratification of patients with APS, a further factor to consider is the …
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral …

Objective This study aimed to assess prospectively the role of anti-ß2-glycoprotein I domain
I antibody (aß2GPI-DI) and the Global Antiphospholipid Syndrome Score (GAPSS) in …